25. 進行性多巣性白質脳症 [臨床試験数:23,薬物数:33(DrugBank:20),標的遺伝子数:7,標的パスウェイ数:36

Searched query = "Progressive multifocal leukoencephalopathy", "PML", "Leukoencephalopathy, progressive multifocal"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2010-020369-26-DE
(EUCTR)
29/11/201018/08/2010High-Dose Corticosteroids for Immune Reconstitution Inflammatory Syndrome in Patients Who Develop Progressive Multifocal Leukoencephalopathy on NatalizumabHigh-Dose Corticosteroids for Immune Reconstitution Inflammatory Syndrome in Patients Who Develop Progressive Multifocal Leukoencephalopathy on Natalizumab Immune Reconstitution Inflammatory Syndrome
MedDRA version: 12.1;Level: PT;Classification code 10054014;Term: Immune reconstitution syndrome
Product Name: methylprednisolone
INN or Proposed INN: METHYLPREDNISOLONE
Product Name: prednisolone
INN or Proposed INN: PREDNISOLONE
Product Name: prednisolone
INN or Proposed INN: PREDNISOLONE
Product Name: prednisolone
INN or Proposed INN: PREDNISOLONE
Product Name: prednisolone
INN or Proposed INN: PREDNISOLONE
Product Name: prednisolone
INN or Proposed INN: PREDNISOLONE
Product Name: prednisolone
INN or Proposed INN: PREDNISOLONE
Biogen IdecNULLNot RecruitingFemale: yes
Male: yes
20Germany
2NCT01211665
(ClinicalTrials.gov)
September 201029/7/2010Corticosteroids for Immune Reconstitution Inflammatory Syndrome (IRIS)High-Dose Corticosteroids for Immune Reconstitution Inflammatory Syndrome in Patients Who Develop Progressive Multifocal Leukoencephalopathy on NatalizumabImmune Reconstitution Inflammatory Syndrome;Leukoencephalopathy, Progressive MultifocalDrug: Methylprednisolone;Drug: PrednisoloneBiogenElan PharmaceuticalsTerminated18 YearsN/AAll3Phase 4United States;Germany